Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Inventory Average (2019 - 2025)

10x Genomics' Inventory Average history spans 7 years, with the latest figure at $59.1 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 33.22% year-over-year to $59.1 million; the TTM value through Dec 2025 reached $59.1 million, down 33.22%, while the annual FY2025 figure was $69.7 million, 11.07% down from the prior year.
  • Inventory Average for Q4 2025 was $59.1 million at 10x Genomics, down from $65.5 million in the prior quarter.
  • Across five years, Inventory Average topped out at $91.2 million in Q3 2024 and bottomed at $34.2 million in Q1 2021.
  • The 5-year median for Inventory Average is $76.0 million (2022), against an average of $70.3 million.
  • The largest annual shift saw Inventory Average surged 103.15% in 2021 before it plummeted 33.22% in 2025.
  • A 5-year view of Inventory Average shows it stood at $55.6 million in 2021, then soared by 44.24% to $80.1 million in 2022, then dropped by 3.52% to $77.3 million in 2023, then grew by 14.57% to $88.6 million in 2024, then tumbled by 33.22% to $59.1 million in 2025.
  • Per Business Quant, the three most recent readings for TXG's Inventory Average are $59.1 million (Q4 2025), $65.5 million (Q3 2025), and $71.8 million (Q2 2025).